<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="83033">
  <stage>Registered</stage>
  <submitdate>1/08/2008</submitdate>
  <approvaldate>25/08/2008</approvaldate>
  <actrnumber>ACTRN12608000423314</actrnumber>
  <trial_identification>
    <studytitle>Effect of statin ingestion on muscle function at rest and following acute exercise in humans</studytitle>
    <scientifictitle>Effect of simvastatin ingestion on muscle function at rest and following acute exercise in healthy humans</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Statin-induced myopathy</healthcondition>
    <conditioncode>
      <conditioncode1>Other</conditioncode1>
      <conditioncode2>Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis)</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Healthy males (18-35yrs) will ingest 80 mg/day of simvastatin for 28 days and then perform a single bout (1hr) of prolonger moderate intensiity exercise.</interventions>
    <comparator>Placebo group in doubel blinded fashion. Placebo will be an identical sugar pill. Placebo will be taken orally once per day for 28 days.</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>To assess disturbance in skeletal muscle mitochondrial function. Biochemical assays will be performed on muscle biopsy samples to analyse mitochondrial enzyme function and protein expression. Also signalling proteins and their gene transcripts will be measured to assess mitochondrial biogenesis.</outcome>
      <timepoint>4 weeks</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Markers of mitochondrial biogenesis, including PGC-1 alpha, NFR-1, Tfam and AMPK will be assessed in muscle biopsy samples.</outcome>
      <timepoint>4 weeks</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Healthy males, (18-35yrs) normal renal, liver and thyroid function. no other mediciations for histories of diease.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>35</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Males</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>abnormal renal, thyroid and liver function</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Diagnosis</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Pharmacodynamics</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/10/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>24</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>The University of Melbourne</primarysponsorname>
    <primarysponsoraddress>Grattan St, Parkville, Victoria, 3010</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>The University of Melbourne</fundingname>
      <fundingaddress>Grattan St, Parkville, Victoria, 3010</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Th eprimary purpose of this study is the examine the effect of statin medication on skeletal muscle metabolism at rest and during and after acute exercise. We hypothesise that high dose statin ingestion will lead to reductions in mitochondrial function and/or number and thus altering muscle metabolism.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Not yet submitted</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname />
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate>4/08/2008</ethicsubmitdate>
      <ethiccountry />
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Craig Goodman</name>
      <address>Department of Physiology,  The University of Melbourne, Grattan St, Parkville, 3010</address>
      <phone>03 8344 6669</phone>
      <fax />
      <email>goodmanc@unimelb.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Craig Goodman</name>
      <address>Department of Physiology, The University of Melbourne, Grattan St, Parkville, 3010</address>
      <phone>03 8344 6669</phone>
      <fax />
      <email>goodmanc@unimelb.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Craig Goodman</name>
      <address>Department of Physiology, The University of Melbourne, Grattan St, Parkville, 3010</address>
      <phone />
      <fax />
      <email>goodmanc@unimelb.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>